Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

A man with Isaac's syndrome affecting only one side of his body improved after immune system-targeted treatment.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Long-term finasteride use doesn't change bone density or metabolism.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

A rare EGFR mutation in newborns leads to severe health issues and early death.

Using cidofovir cream for a rare skin disease can cause skin darkening.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

A bald man grew hair on his head after taking a drug called diazoxide, but lost it again when he stopped the medication.

New treatments for lupus show promise, but more research is needed, especially for children.

Targeted cancer therapies often cause serious skin problems that need careful management.

Panniculitis in dermatomyositis is rare, more common in women, and may persist despite treatment.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.